Skip to content

Message from the Chair

Markus Bredel, M.D., Ph.D.
Markus Bredel, M.D., Ph.D.

Welcome to the Department of Radiation Oncology at the Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine. As one of the largest and most technically advanced radiation oncology departments in the nation, we are proud to be at the forefront of cancer care, dedicated to the tripartite mission of Sylvester and the Miller School of Medicine of providing life-changing and compassionate treatment, advancing groundbreaking research, and educating future leaders of radiation oncology and science. Our commitment to excellence is reflected not only in our patient outcomes but also in our collaborative efforts across disciplines, ensuring that we remain international trailblazers in the field.

At the heart of our mission lies compassionate patient care. We embrace every patient, regardless of their background or circumstances, ensuring they receive the highest quality of care. We understand that a cancer diagnosis can be daunting, and our team of over 200 experts is committed to supporting our patients every step of the way. With a fleet of 18 modern radiation delivery devices—including cutting-edge technologies like proton beam therapy (PBT), Edge HyperArc brain radiosurgery (SRS) and stereotactic body radiation therapy (SBRT), MR-guided adaptive radiation therapy (MR-LINAC), Ethos CT-adaptive radiation therapy, image-guided radiation therapy (IGRT), volumetric modulated arc therapy (VMAT), intensity modulated radiation therapy (IMRT), intraoperative radiation therapy (IORT), and brachytherapy—we offer a comprehensive spectrum of advanced treatment options tailored to go above and beyond to meet the unique needs of each of our patients. Our integrative departmental approach, encompassing clinical, physics, and biology divisions, fosters collaboration that elevates the standard of care we provide.

Our dedication to excellence extends beyond clinical care. We actively collaborate with our multidisciplinary colleagues in hematology-oncology, surgical oncology, and various other specialties under the Sylvester umbrella, driving innovation and expanding our collective expertise. Together, we are advancing clinical, translational, and basic research that has the potential to transform cancer treatment and improve patient outcomes. We are deeply committed to education, nurturing the next generation of radiation oncology and medical physics residents, dosimetrists, radiation therapists, and undergraduate, graduate, and post-graduate students, who will continue to push the boundaries of what is possible in cancer care. We are honored to be international leaders in radiation oncology as we strive to make a meaningful impact in the lives of our wonderful patients and the broader community.

Markus Bredel, M.D., Ph.D.
Chairman and Sylvester Professor of Radiation Oncology